跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
LIDOCAINE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
LIDOCAINE
Authorized
STANDARD
LIDOCAINE
the mentholatum company of canada ltd
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e3669bc97ae7b9e3
Company
the mentholatum company of canada ltd
Type
Standard
Approval Details
Approval Id
e3669bc97ae7b9e3
Drug Approval Canada Name
LIDOCAINE
Product Name
LIDOCAINE
Status
Marketed
Status Date
2019-05-21
Original Market Date
2019-05-21
Din
02485311
Drug Class
Human
Dosage Form
Gel
Route Of Administration
Topical
Schedule
OTC
Ahfs
84:08.00
Atc Original
D04AB01 LIDOCAINE
Atc Name
d 04 ab 01
Aig Number
0103565009
Company Name
the mentholatum company of canada ltd
Company Address
UNIT 205B, 110 Hannover Dr., St. Catharines, Ontario, Canada, L2W 1A4
Active Ingredients
LIDOCAINE
4 %
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e3669bc97ae7b9e3
Type
Standard
Back to Health Canada Approvals